BIO Submits Comments to the Departments of Labor, Treasury, and Health and Human Services on the Request for Information Regarding Provider Nondiscrimination
<p align="right">
</p>
<p align="right">
June 10, 2014</p>
<p align="left">
</p>
<p align="left">
Jacob J. Lew</p>
<p align="left">
Secretary, Department of the Treasury</p>
<p align="left">
1500 Pennsylvania Avenue, NW</p>
<p align="left">
Washington, D.C. 20220</p>
<p align="left">
</p>
<p align="left">
Thomas E. Perez</p>
<p align="left">
Secretary, Department of Labor</p>
<p align="left">
Frances Perkins Building, 200 Constitution Ave., NW,</p>
<p align="left">
Washington, DC 20210</p>
<p align="left">
</p>
<p align="left">
Sylvia Mathews Burwell</p>
<p align="left">
Secretary, Department of Health and Human Services</p>
<p align="left">
200 Independence Avenue, SW</p>
<p align="left">
Washington, DC 20201</p>
<p align="left">
</p>
<p align="left">
<strong>Re: Request for Information Regarding Provider Nondiscrimination </strong></p>
<p align="left">
</p>
<p>
Dear Secretaries Lew, Perez, and Burwell:</p>
<p>
</p>
<p>
The Biotechnology Industry Organization (BIO) is pleased to submit the following comments on the “Request for Information Regarding Provider Nondiscrimination” (the “RFI”) issued by the Departments of Treasury, Labor, and Health and Human Services (“the Departments”) on March 12, 2014.<a href="#_ftn1" name="_ftnref1" title="">[1]</a></p>
<p>
</p>
<p>
BIO represents more than 1,000 biotechnology companies, academic institutions, state biotechnology centers, and related organizations across the United States and in more than 30 other nations. BIO's members develop medical products and technologies to treat patients afflicted with serious diseases, to delay the onset of these diseases, or to prevent them in the first place. In that way, our members’ novel therapeutics, vaccines, and diagnostics not only have improved health outcomes, including productivity and quality of life, but also have reduced health care expenditures due to fewer physician office visits, hospitalizations, and surgical interventions.</p>
<div>
<br clear="all" />
<hr align="left" size="1" width="33%" />
<div id="ftn1">
<p>
<a href="#_ftnref1" name="_ftn1" title="">[1]</a> 79 Fed. Reg. 14,052 (March 12, 2014).</p>
</div>
</div>
<p>
</p>
June 10, 2014
Jacob J. Lew
Secretary, Department of the Treasury
1500 Pennsylvania Avenue, NW
Washington, D.C. 20220
Thomas E. Perez
Secretary, Department of Labor
Frances Perkins Building, 200 Constitution Ave., NW,
Washington, DC 20210
Sylvia Mathews Burwell
Secretary, Department of Health and Human Services
200 Independence Avenue, SW
Washington, DC 20201
Re: Request for Information Regarding Provider Nondiscrimination
Dear Secretaries Lew, Perez, and Burwell:
The Biotechnology Industry Organization (BIO) is pleased to submit the following comments on the “Request for Information Regarding Provider Nondiscrimination” (the “RFI”) issued by the Departments of Treasury, Labor, and Health and Human Services (“the Departments”) on March 12, 2014.[1]
BIO represents more than 1,000 biotechnology companies, academic institutions, state biotechnology centers, and related organizations across the United States and in more than 30 other nations. BIO's members develop medical products and technologies to treat patients afflicted with serious diseases, to delay the onset of these diseases, or to prevent them in the first place. In that way, our members’ novel therapeutics, vaccines, and diagnostics not only have improved health outcomes, including productivity and quality of life, but also have reduced health care expenditures due to fewer physician office visits, hospitalizations, and surgical interventions.